Wolverine Trading’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $353K | Buy |
39,500
+21,800
| +123% | +$170K | ﹤0.01% | 4148 |
|
|
2025
Q2 | $112K | Buy |
17,700
+5,600
| +46% | +$32K | ﹤0.01% | 4134 |
|
|
2025
Q1 | $56.4K | Sell |
12,100
-11,000
| -48% | -$91K | ﹤0.01% | 4391 |
|
|
2024
Q4 | $214K | Buy |
23,100
+7,700
| +50% | +$70.7K | ﹤0.01% | 4431 |
|
|
2024
Q3 | $115K | Buy |
+15,400
| New | +$140K | ﹤0.01% | 4311 |
|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$24K | – | 4689 |
|
|
2023
Q4 | $24K | Buy |
+10,000
| New | +$23.5K | ﹤0.01% | 4356 |
|
|
2023
Q3 | – | Sell |
-16,400
| Closed | -$125K | – | 4641 |
|
|
2023
Q2 | $125K | Buy |
+16,400
| New | +$152K | ﹤0.01% | 3704 |
|
|
2022
Q2 | – | Sell |
-7,100
| Closed | -$297K | – | 4775 |
|
|
2022
Q1 | $297K | Sell |
7,100
-3,000
| -30% | -$132K | ﹤0.01% | 3900 |
|
|
2021
Q4 | $456K | Buy |
10,100
+2,600
| +35% | +$118K | ﹤0.01% | 3586 |
|
|
2021
Q3 | $388K | Sell |
7,500
-8,000
| -52% | -$484K | ﹤0.01% | 4321 |
|
|
2021
Q2 | $992K | Buy |
15,500
+8,800
| +131% | +$565K | ﹤0.01% | 2797 |
|
|
2021
Q1 | $605K | Sell |
6,700
-6,800
| -50% | -$696K | ﹤0.01% | 3445 |
|
|
2020
Q4 | $1.25M | Buy |
13,500
+9,300
| +221% | +$854K | ﹤0.01% | 2155 |
|
|
2020
Q3 | $438K | Buy |
+4,200
| New | +$453K | ﹤0.01% | 2959 |
|
|
2019
Q2 | – | Sell |
-17,100
| Closed | -$864K | – | 4555 |
|
|
2019
Q1 | $864K | Buy |
+17,100
| New | +$1.01M | ﹤0.01% | 2226 |
|
|
2017
Q3 | – | Sell |
-11,800
| Closed | -$396K | – | 4543 |
|
|
2017
Q2 | $396K | Buy |
11,800
+4,600
| +64% | +$142K | ﹤0.01% | 2676 |
|
|
2017
Q1 | $208K | Buy |
+7,200
| New | +$219K | ﹤0.01% | 3484 |
|
|
2016
Q3 | – | Sell |
-29,300
| Closed | -$825K | – | 4685 |
|
|
2016
Q2 | $825K | Buy |
+29,300
| New | +$1.15M | ﹤0.01% | 1751 |
|
Other funds holding EBS
OHA
PCM
